New Markers of Inflammation and Endothelial Cell Activation: Part I

By P. Szmitko, Chao-Hung Wang, R. Weisel, John R. de Almeida, T. Anderson, S. Verma. Circulation, 2003

793 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Biomarkers in acute cardiac disease: the present and the future. (2006, background): “Many of these improve our understanding of pathophysiology (3, 4 ).”
Endothelial Dysfunction and Hypertension. (2016, background): “Activated platelets binds to CD40 on ECs (Vanhoutte et al. 2009; Tuttolomondo et al. 2012; Tummala et al. 1999; Szmitko et al. 2003).”
Inflammatory Cytokines in Vascular Dysfunction and Vascular Disease (2009, background): “The delayed inflammatory response leads to ECM deposition, granular tissue formation and connective tissue growth [1,2].”
Vascularization Strategies for Tissue Engineering (2009, neutral): “References [49–62] PECAM-1, platelet=endothelial cell adhesion molecule-1; VE-cadherin, vascular endothelial cadherin; eNOS, endothelial nitric oxide synthase; vWF, von Willebrand factor; VCAM-1, vascular cell adhesion molecule-1; ICAM-1, intercellular adhesion molecule-1; SM, smooth muscle; NMHC-B,”